ECMO

  • EOLIA: Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome
    This phase 3, multicenter, international, randomized controlled trial is designed to evaluate the efficacy of ECMO combined with mechanical ventilation vs. standard-of-care mechanical ventilation alone in the management of severe ARDS.
    PI: Daniel Brodie, MD and Matthew Bacchetta, MD
    Contact:
    Price Family Center for Comprehensive Chest Care (877) 586-4212
  • Ketamine and Extracorporeal Membrane Oxygenation
    This single-center, randomized, open-label study is designed to evaluate the efficacy of ketamine in reducing sedative and pain medication requirements in patients receiving ECMO for severe ARDS.
    PI: Daniel Brodie, MD
    Contact:
    Amy Dzierba, PharmD (212) 305-5852